| [1] |
Casazza F, Bongarzoni A, Capozi A, et al. Regional right ventricular dysfunction in acute pulmonary embolism and right ventricular infarction[J]. Eur J Echocardiogr,2005, 6(1):11-14.
|
| [2] |
Boissier F, Katsahian S, Razazi K, et al. Prevalence and prognosis of cor pulmonale during protective ventilation for acute respiratory distress syndrome[J]. Intensive Care Med, 2013, 39(10):1725-1733.
|
| [3] |
Markin NW, Gmelch BS, Griffee MJ, et al. A review of 364 perioperative rescue echocardiograms: findings of an an‐esthesiologist-staffed perioperative echocardiography service[J]. J Cardiothorac Vasc Anesth, 2015, 29(1):82-88.
|
| [4] |
Konstam MA, Kiernan MS, Bernstein D, et al. Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association[J]. Circu‐lation, 2018, 137(20):e578-e622.
|
| [5] |
Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 Updated consensus statement on the diagnosis and treat‐ment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EP‐PVDN), endorsed by AEPC, ESPR and ISHLT[J]. J Heart Lung Transplant, 2019, 38(9):879-901.
|
| [6] |
Guazzi M, Naeije R. Pulmonary Hypertension in heart fail‐ure: pathophysiology, pathobiology, and emerging clinical perspectives[J]. J Am Coll Cardiol, 2017, 69(13):1718-1734.
|
| [7] |
Walsh NP, Gleeson M, Shephard RJ, et al. Position state‐ment. Part one: Immune function and exercise[J]. Exerc Immunol Rev, 2011, 17:6-63.
|
| [8] |
Reuse C, Vincent JL, Pinsky MR. Measurements of right ventricular volumes during fluid challenge[J]. Chest,1990, 98(6):1450-1454.
|
| [9] |
van der Bruggen C, Tedford RJ, Handoko ML, et al. RV pressure overload: from hypertrophy to failure[J]. Cardio‐vasc Res, 2017, 113(12):1423-1432.
|
| [10] |
Crystal GJ, Pagel PS. Right ventricular perfusion: physiolo‐gy and clinical implications[J]. Anesthesiology, 2018,128(1):202-218.
|
| [11] |
Fischer LG, Aken HV, Bürkle H. Management of pulmo‐nary hypertension: physiological and pharmacological considerations for anesthesiologists[J]. Anesth Analg,2003, 96(6):1603-1616.
|
| [12] |
Biondi JW, Schulman DS, Soufer R, et al. The effect of in‐cremental positive end-expiratory pressure on right ven‐tricular hemodynamics and ejection fraction[J]. Anesth Analg, 1988, 67(2):144-151.
|
| [13] |
Poelaert JI, Visser CA, Everaert JA, et al. Doppler evalua‐tion of right ventricular outflow impedance during posi‐tive-pressure ventilation[J]. J Cardiothorac Vasc Anesth,1994, 8(4):392-397.
|
| [14] |
Vieillard-Baron A, Jardin F. Why protect the right ventricle in patients with acute respiratory distress syndrome?[J].Curr Opin Crit Care, 2003, 9(1):15-21.
|
| [15] |
Grignola JC, Domingo E. Acute right ventricular dysfunc‐tion in intensive care unit[J]. Biomed Res Int, 2017, 2017:8217105.
|
| [16] |
Tissot C, Singh Y, Sekarski N. Echocardiographic evalua‐tion of ventricular function-for the neonatologist and pe‐diatric intensivist[J]. Front Pediatr, 2018, 6:79.
|
| [17] |
Krishnan S, Schmidt GA. Acute right ventricular dysfunc‐tion: real-time management with echocardiography[J].Chest, 2015, 147(3):835-846.
|
| [18] |
Lai WW, Gauvreau K, Rivera ES, et al. Accuracy of guide‐line recommendations for two-dimensional quantifica‐tion of the right ventricle by echocardiography[J]. Int J Cardiovasc Imaging, 2008, 24(7):691-698.
|
| [19] |
Anavekar NS, Gerson D, Skali H, et al. Two-dimensional as‐sessment of right ventricular function: an echocardio‐graphic-MRI correlative study[J]. Echocardiography,2007, 24(5):452-456.
|
| [20] |
Nass N, McConnell MV, Goldhaber SZ, et al. Recovery of re‐gional right ventricular function after thrombolysis for pulmonary embolism[J]. Am J Cardiol, 1999, 83(5):804-806, A10.
|
| [21] |
Zornoff LA, Skali H, Pfeffer MA, et al. Right ventricular dys‐function and risk of heart failure and mortality after myo‐cardial infarction[J]. J Am Coll Cardiol, 2002, 39(9):1450-1455.
|
| [22] |
Anavekar NS, Skali H, Bourgoun M, et al. Usefulness of right ventricular fractional area change to predict death,heart failure, and stroke following myocardial infarction(from the VALIANT ECHO Study)[J]. Am J Cardiol, 2008,101(5):607-612.
|
| [23] |
Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), Internation‐al Society for Heart and Lung Transplantation (ISHLT)[J].Eur Heart J, 2016, 37(1):67-119.
|
| [24] |
Brissaud O, Botte A, Cambonie G, et al. Experts' recom‐mendations for the management of cardiogenic shock in children[J]. Ann Intensive Care, 2016, 6(1):14.
|
| [25] |
Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American Col‐lege of Cardiology (ACC), the American Heart Association(AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019[J].Catheter Cardiovasc Interv, 2019, 94(1):29-37.
|
| [26] |
Harjola VP, Mebazaa A, Čelutkienė J, et al. Contemporary management of acute right ventricular failure: a state‐ment from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology[J]. Eur J Heart Fail, 2016, 18(3):226-241.
|
| [27] |
Paternot A, Repessé X, Vieillard-Baron A. Rationale and description of right ventricle-protective ventilation in AR‐DS[J]. Respir Care, 2016, 61(10):1391-1396.
|
| [28] |
Xiaolei G, Limin Z, Mingjie Z, et al. Utilizing spontaneous ventilation modes in patients underwent corrective sur‐gery for right ventricular outflow tract obstructive con‐genital heart disease: a crossover study[J]. Rev. Cardio‐vasc. Med, 2023, 24(5): 143.
|
| [29] |
Ventetuolo CE, Klinger JR. Management of acute right ven‐tricular failure in the intensive care unit[J]. Ann Am Tho‐rac Soc, 2014, 11(5):811-822.
|
| [30] |
Wanner PM, Filipovic M. The right ventricle-you may for‐get it, but It will Not forget you[J]. J Clin Med, 2020,9(2):432.
|
| [31] |
Lu GP, Yan G, Chen Y, et al. The passive leg raise test to pre‐dict fluid responsiveness in children--preliminary obser‐vations[J]. Indian J Pediatr, 2015, 82(1):5-12.
|
| [32] |
Han D, Pan S, Wang X, et al. Different predictivity of fluid responsiveness by pulse pressure variation in children af‐ter surgical repair of ventricular septal defect or tetralogy of Fallot[J]. Paediatr Anaesth, 2017, 27(10):1056-1063.
|
| [33] |
Favia I, Romagnoli S, Di Chiara L, et al. Predicting Fluid Re‐sponsiveness in children undergoing cardiac surgery af‐ter cardiopulmonary bypass[J]. Pediatr Cardiol, 2017,38(4):787-793.
|
| [34] |
Long E, Oakley E, Duke T, et al. Does respiratory variation in inferior vena cava diameter predict fluid responsive‐ness: a systematic review and meta-analysis[J]. Shock.2017, 47(5):550-559.
|
| [35] |
Lee JH, Kim EH, Jang YE, et al. Fluid responsiveness in the pediatric population[J]. Korean J Anesthesiol, 2021,74(2):188.
|
| [36] |
龚霄雷,朱丽敏,李春香,等. 早期液体负平衡对右心室增大性先天性心脏病术后早期恢复的影响[J]. 中国小儿急救医学, 2018, 25(9):651-654,660.
|
| [37] |
王小亭, 刘大为, 张宏民, 等. 重症右心功能管理专家共识[J]. 中华内科杂志, 2017, 56(12):962-973.
|
| [38] |
Kirbas A, Yalcin Y, Tanrikulu N, et al. Comparison of in‐haled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery[J].Cardiol J, 2012, 19(4):387-394.
|
| [39] |
Antoniou T, Koletsis EN, Prokakis C, et al. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery[J]. J Cardiothorac Vasc Anesth, 2013, 27(3):459-466.
|
| [40] |
Karakitsos D, Papanikolaou J, Karabinis A, et al. Acute ef‐fect of sildenafil on central hemodynamics in mechanical‐ly ventilated patients with WHO group III pulmonary hy‐pertension and right ventricular failure necessitating ad‐ministration of dobutamine[J]. Int J Cardiol, 2013, 167(3):848-854.
|
| [41] |
Sitbon O, Jaïs X, Savale L, et al. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study[J]. Eur Respir J, 2014, 43(6):1691-1697.
|
| [42] |
Ondrus T, Kanovsky J, Novotny T, et al. Right ventricular myocardial infarction: From pathophysiology to prognosis[J]. Exp Clin Cardiol, 2013, 18(1):27-30.
|
| [43] |
Leather HA, Segers P, Berends N, et al. Effects of vasopres‐sin on right ventricular function in an experimental mod‐el of acute pulmonary hypertension[J]. Crit Care Med,2002, 30(11):2548-2552.
|
| [44] |
Masarwa R, Paret G, Perlman A, et al. Role of vasopressin and terlipressin in refractory shock compared to conven‐tional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis[J]. Crit Care, 2017, 21(1):1.
|
| [45] |
Liu ZM, Chen J, Kou Q, et al. Terlipressin versus norepi‐nephrine as infusion in patients with septic shock: a mul‐ticentre, randomised, double-blinded trial[J]. Intensive Care Med, 2018, 44(11):1816-1825.
|
| [46] |
Meyer S, Gortner L, McGuire W, et al. Vasopressin in cate‐cholamine-refractory shock in children[J]. Anaesthesia,2008, 63(3):228-234.
|
| [47] |
Siehr SL, Feinstein JA, Yang W, et al. Hemodynamic effects of phenylephrine, vasopressin, and epinephrine in chil‐dren with pulmonary hypertension: a pilot study[J]. Pedi‐atr Crit Care Med, 2016, 17(5):428-437.
|
| [48] |
Yilmaz MB, Yontar C, Erdem A, et al. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure[J].Heart Vessels, 2009, 24(1):16-21.
|
| [49] |
Qiu J, Jia L, Hao Y, et al. Efficacy and safety of levosimen‐dan in patients with acute right heart failure: a meta-anal‐ysis[J]. Life Sci, 2017, 184:30-36.
|
| [50] |
Felker GM, Benza RL, Chandler AB, et al. Heart failure eti‐ology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study[J]. J Am Coll Cardiol, 2003, 41(6):997-1003.
|
| [51] |
Tarvasmäki T, Lassus J, Varpula M, et al. Current real-life use of vasopressors and inotropes in cardiogenic shock -adrenaline use is associated with excess organ injury and mortality[J]. Crit Care, 2016, 20(1):208.
|
| [52] |
Kapur NK, Esposito ML, Bader Y, et al. Mechanical circula‐tory support devices for acute right ventricular failure[J].Circulation, 2017, 136(3):314-326.
|